Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Miodrag Janić

Showing results (1-10 of 45) with videos related to

Pageof 5
Sort By:
Biomed Research International|August 30, 2014
Arterial stiffness and cardiovascular therapyMiodrag Janić, Mojca Lunder, Mišo Sabovič
Biomedicines|January 23, 2024
Obesity and Insulin Resistance in Asthma Pathogenesis and Clinical OutcomesSabina Škrgat, Matevž Harlander, Miodrag Janić
Current Vascular Pharmacology|February 8, 2018
Prevention of Vascular Complications in Diabetes Mellitus Patients: Focus on the Arterial WallMojca Lunder, Miodrag Janić, Mišo Šabovič
Medical Hypotheses|April 17, 2013
A new anti-ageing strategy focused on prevention of arterial ageing in the middle-aged populationMiodrag Janić, Mojca Lunder, Mišo Sabovič
Biomed Research International|March 31, 2015
A low-dose combination of fluvastatin and valsartan: a new "drug" and a new approach for decreasing the arterial ageMiodrag Janić, Mojca Lunder, Mišo Šabovič
International Journal of Molecular Sciences|April 3, 2021
Treating Arterial Ageing in Patients with Diabetes: From Mechanisms to Effective DrugsMojca Lunder, Miodrag Janić, Mišo Šabovič
International Journal of Molecular Sciences|March 13, 2019
Molecular Mechanisms Responsible for Diastolic Dysfunction in Diabetes Mellitus PatientsJovana Nikolajević Starčević, Miodrag Janić, Mišo Šabovič
Atherosclerosis|February 9, 2011
Subtherapeutic, low-dose fluvastatin improves functional and morphological arterial wall properties in apparently healthy, middle-aged males--a pilot studyMojca Lunder, Miodrag Janić, Sara Habjan, et al.
Journal of Cardiopulmonary Rehabilitation and Prevention|November 23, 2013
A combination of low-dose fluvastatin and valsartan decreases inflammation and oxidative stress in apparently healthy middle-aged malesMiodrag Janić, Mojca Lunder, Marija Prezelj, et al.
VASA. Zeitschrift Fur Gefasskrankheiten|March 9, 2019
The influence of May-Thurner syndrome on post-thrombotic syndrome in young womenAna Kovač, Miodrag Janić, Dašmir Nuredini, et al.
Pageof 5

Showing results (1-10 of 45) with videos related to

Sort By:
Pageof 5
Biomed Research International|August 30, 2014
Arterial stiffness and cardiovascular therapyMiodrag Janić, Mojca Lunder, Mišo Sabovič
Biomedicines|January 23, 2024
Obesity and Insulin Resistance in Asthma Pathogenesis and Clinical OutcomesSabina Škrgat, Matevž Harlander, Miodrag Janić
Current Vascular Pharmacology|February 8, 2018
Prevention of Vascular Complications in Diabetes Mellitus Patients: Focus on the Arterial WallMojca Lunder, Miodrag Janić, Mišo Šabovič
Medical Hypotheses|April 17, 2013
A new anti-ageing strategy focused on prevention of arterial ageing in the middle-aged populationMiodrag Janić, Mojca Lunder, Mišo Sabovič
Biomed Research International|March 31, 2015
A low-dose combination of fluvastatin and valsartan: a new "drug" and a new approach for decreasing the arterial ageMiodrag Janić, Mojca Lunder, Mišo Šabovič
International Journal of Molecular Sciences|April 3, 2021
Treating Arterial Ageing in Patients with Diabetes: From Mechanisms to Effective DrugsMojca Lunder, Miodrag Janić, Mišo Šabovič
International Journal of Molecular Sciences|March 13, 2019
Molecular Mechanisms Responsible for Diastolic Dysfunction in Diabetes Mellitus PatientsJovana Nikolajević Starčević, Miodrag Janić, Mišo Šabovič
Atherosclerosis|February 9, 2011
Subtherapeutic, low-dose fluvastatin improves functional and morphological arterial wall properties in apparently healthy, middle-aged males--a pilot studyMojca Lunder, Miodrag Janić, Sara Habjan, et al.
Journal of Cardiopulmonary Rehabilitation and Prevention|November 23, 2013
A combination of low-dose fluvastatin and valsartan decreases inflammation and oxidative stress in apparently healthy middle-aged malesMiodrag Janić, Mojca Lunder, Marija Prezelj, et al.
VASA. Zeitschrift Fur Gefasskrankheiten|March 9, 2019
The influence of May-Thurner syndrome on post-thrombotic syndrome in young womenAna Kovač, Miodrag Janić, Dašmir Nuredini, et al.
Pageof 5